These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 1900223)

  • 1. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators.
    Habib GB; Heibig J; Forman SA; Brown BG; Roberts R; Terrin ML; Bolli R
    Circulation; 1991 Mar; 83(3):739-46. PubMed ID: 1900223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
    Wackers FJ; Terrin ML; Kayden DS; Knatterud G; Forman S; Braunwald E; Zaret BL
    J Am Coll Cardiol; 1989 Apr; 13(5):998-1005. PubMed ID: 2494246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction.
    de Boer MJ; Suryapranata H; Hoorntje JC; Reiffers S; Liem AL; Miedema K; Hermens WT; van den Brand MJ; Zijlstra F
    Circulation; 1994 Aug; 90(2):753-61. PubMed ID: 8044944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
    Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrected TIMI frame counts correlate with stenosis severity and infarct zone wall motion after thrombolytic therapy.
    Amos DJ; French JK; Andrews J; Ashton NG; Williams BF; Whitlock RM; Manda SO; White HD
    Am Heart J; 2001 Apr; 141(4):586-91. PubMed ID: 11275924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the collateral circulation on myocardial salvage in patients with acute myocardial infarction].
    Nakamura M
    J Cardiol; 1991; 21(1):1-13. PubMed ID: 1817169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy reduces the incidence of left ventricular thrombus after anterior myocardial infarction. Relationship to vessel patency and infarct size.
    Pizzetti G; Belotti G; Margonato A; Carlino M; Gerosa S; Carandente O; Chierchia SL
    Eur Heart J; 1996 Mar; 17(3):421-8. PubMed ID: 8737217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.
    Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A
    J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
    J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.
    White HD; Cross DB; Elliott JM; Norris RM; Yee TW
    Circulation; 1994 Jan; 89(1):61-7. PubMed ID: 8281696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
    Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
    Goodman SG; Langer A; Ross AM; Wildermann NM; Barbagelata A; Sgarbossa EB; Wagner GS; Granger CB; Califf RM; Topol EJ; Simoons ML; Armstrong PW
    Circulation; 1998 Feb; 97(5):444-50. PubMed ID: 9490238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.
    Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK
    Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thrombolysis on acute mitral regurgitation during evolving myocardial infarction. Experience from the Thrombolysis in Myocardial Infarction (TIMI) Trial.
    Lehmann KG; Francis CK; Sheehan FH; Dodge HT
    J Am Coll Cardiol; 1993 Sep; 22(3):714-9. PubMed ID: 8354803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction.
    Gore JM; Roberts R; Ball SP; Montero A; Goldberg RJ; Dalen JE
    Am J Cardiol; 1987 Jun; 59(15):1234-8. PubMed ID: 3109227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute coronary artery obstruction in myocardial infarction: overview of thrombolytic therapy.
    Hugenholtz PG
    J Am Coll Cardiol; 1987 Jun; 9(6):1375-84. PubMed ID: 3108346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction.
    Mounsey JP; Skinner JS; Hawkins T; MacDermott AF; Furniss SS; Adams PC; Kesteven PJ; Reid DS
    Br Heart J; 1995 Oct; 74(4):348-53. PubMed ID: 7488444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.